The Top 15 Best-Selling Drugs of 2017
Amid Talk of Curbing Prices, Most Treatments Show Sales Gains
Cell Therapy Production Moves to Factory Floor
Assembly Lines Are Preparing to Churn out Safe, Reliable, and Affordable Constructs
RNAi Therapeutics: To the Liver ... and Beyond
RNAi Therapy Components Are Surviving Degradation, Staying Potent, and Reaching More Targets Than Ever
Why Cardiology Is Ripe to Become the Next Frontier for Precision Medicine
Cardiovascular Disease Applications Are Set to Focus on Highly Individualized Variables for Therapy
For full access to this article login to GEN Select now.
CGH Sheds Its Light on Disease Etiology
Diseases that Have Defied Description Can Now Be Described and Explained
- Array comparative genomic hybridization (CGH) is illuminating DNA copy number variations (CNV) throughout the genome to diagnose disease etiology and to help tailor treatment regimens for patients to improve health outcomes. In January 2007, the College of American Pathologists and American Society of Clinical Oncology (CAP/ASCO) published guideline ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.